The page is the record's research on the issuer — no analyst, no rating, no view.

PHARMA MAR, S.A. (ES0169501022) — research page

ES · es-cm-kg/XMAD/ES0169501022 · as of 2026-11-06

Identity and listing

The issuer is PHARMA MAR, S.A., listed on BME Madrid under ticker ES0169501022, with ISIN ES0169501022 and LEI 959800QWKZ45ZQC2AV58. The security type, segment, sector and jurisdiction are not on the record. The listing status is listed, not halted.

fieldvaluesource · read date
namePHARMA MAR, S.A.source · 2026-11-06
exchangeBME Madridsource · 2026-11-06
tickerES0169501022source · 2026-11-06
ISINES0169501022source · 2026-11-06
LEI959800QWKZ45ZQC2AV58source · 2026-11-09
security typenot on the record
segmentnot on the record
sectornot on the record
jurisdictionnot on the record
statuslisted, not haltedsource · 2026-11-09

The disclosure read

The record holds 43 filings in the twelve months to 2026-11-06, across 28 filing days. The median gap between filing days is 11 days. The latest filing is dated 2026-11-03, three days before the record date, and is of type Programas de recompra de acciones, estabilización y autocartera. The exchange median cadence gap is 9 days across 122 issuers, the exchange median filings count is 31.0, and the exchange median latency is 8 days. The sector median is not on the record.

filingsmedian gap between filing daysdays from latest filing to as-of
this issuer43113
exchange median: BME Madrid (122 issuers)3198
datetypecategoryfiling
2026-11-03Programas de recompra de acciones, estabilización y autocarteraProgramas de recompra de acciones, estabilización y autocarteraLa Sociedad informa de las operaciones de adquisición de acciones propias en el periodo transcurrido entre el 1 de octubre y el 31 de octubre de 2026.
2026-10-29Sobre Gobierno corporativoSobre Gobierno corporativoLa Sociedad comunica el nombramiento de nueva Directora Financiera del Grupo Pharma Mar.
2026-10-29Sobre negocio y situación financieraSobre negocio y situación financieraLa Sociedad publica información financiera correspondiente al tercer trimestre de 2026.
2026-10-01Programas de recompra de acciones, estabilización y autocarteraProgramas de recompra de acciones, estabilización y autocarteraLa Sociedad informa de las operaciones de adquisición de acciones propias en el periodo transcurrido entre el 1 de septiembre y el 30 de septiembre de 2026.
2026-09-24Sobre negocio y situación financieraSobre negocio y situación financieraLas autoridades sanitarias de Reino Unido aprueban la combinación de Zepzelca® (lurbinectedina) de PharmaMar y atezolizumab (Tecentriq®) en primera línea de mantenimiento para cáncer de pulmón de célula pequeña en estadio avanzado.

window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor of record is not on the record, and neither is its location. The market's record does not carry auditor changes.

Events and halts

The record carries no listing, delisting, name change, domicile change or segment move lines, because this register has no lifecycle type map yet. The halt flag is not set, and the issuer is listed, not halted.

Orderability

The orderability outcome is not determinable for this issuer. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/es/mifid-ii-product-governance/r1, and the chapter is as of 2026-11-04.

rule acm-68000/es/mifid-ii-product-governance/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

No research houses were found on the issuer's own investor-relations page in the pages read.

Open research

No openly published research notes were found on the record.

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

licensorentitlementtitledatesource
none loaded

As-of depth

The vintage of this market is not sealed. No issuer years are sealed, the market's earliest sealed date is not on the record, and the live record began is not on the record.

Sources

6 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1
https://firds.esma.europa.eu/firds/ (identity.exchange)
10.2
https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
10.3
https://mcp.es-cm-kg.ai/events/XMAD/ES0169501022 (the disclosure lines)
10.4
https://www.cnmv.es/portal/Informacion-Privilegiada/Resultado-IP?tipos=<category blob>&fechaDesde=09/11/2025&fechaHasta=09/11/2026 | https://www.cnmv.es/portal/Otra-Informacion-Relevante/Resultado-OIR?tipos=<category blob>&fechaDesde=09/11/2025&fechaHasta=09/11/2026 | https://apiweb.bolsasymercados.es/Market/v1/EQ/ShareDetailsInfo?isin=<roster ISIN> (the halt flag)
10.5
https://es.eu-cm-kg.ai/book/aio.json (the orderability chapter)
10.6
https://mcp.es-cm-kg.ai/record/XMAD/ES0169501022 (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"ES0169501022"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:d96d9b6880531623.